VaramirStart free · no cardSign in
PBYI as of Oct 30 · 23:36 ET
PBYINasdaqPharmaceutical Preparations

Puma Biotechnology, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±34.0%
avg realized
±12.8%
Nov 7 '24±82.7%▼−4.95%×0.06
Feb 27 '25±13.3%▲+19.73%×1.49
May 8 '25±17.0%▼−5.21%×0.31
Aug 7 '25±31.9%▲+12.16%×0.38
Q3 FY25±18.4%▲+22.24%×1.21
Q1 FY26±21.7%▼−25.00%×1.15
May 7 '26±42.0%▲+3.17%×0.08
Q2 FY26±45.0%▲+9.73%×0.22
quarterimplied−85%0+85%realized×
Q2 FY26±45.0%▲+9.73%×0.22
May '26±42.0%▲+3.17%×0.08
Q1 FY26±21.7%▼−25.00%×1.15
Q3 FY25±18.4%▲+22.24%×1.21
Aug '25±31.9%▲+12.16%×0.38
May '25±17.0%▼−5.21%×0.31
2 older reports
Feb '25±13.3%▲+19.73%×1.49
Nov '24±82.7%▼−4.95%×0.06
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

18disclosed supplier and customer ties in sec filingsSEC filings
161managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

5 of 8recent reports where the move came in under the options implied rangeEarnings history
3tracked funds holding PBYIN-PORT · Aug 31 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

PBYI report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±20.3% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.